Article Information
History
- April 1, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Chanawee Hirunpattarasilp1,2,
- Gregory James1,3,
- Felipe Freitas1,
- Huma Sethi4,
- Josef T. Kittler1,
- Jiandong Huo5,6,
- Raymond J. Owens5,6 and
- David Attwell1,*
- 1Department of Neuroscience, Physiology & Pharmacology, University College London, Gower Street, London, WC1E 6BT, UK
- 2HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, 906 Kamphaeng Phet 6 Rd, Talat Bang Khen, Lak Si, Bangkok 10210, Thailand
- 3Department of Neurosurgery, Great Ormond Street Hospital, London, WC1N 3JH, UK
- 4National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, UK
- 5Division of Structural Biology, Nuffield Department of Medicine, University of Oxford, OX3 7BN, UK
- 6Protein Production UK, The Research Complex at Harwell, and Rosalind Franklin Institute, Harwell Science & Innovation Campus, Didcot, OX11 0GD, UK
- ↵*Corresponding author; email: d.attwell{at}ucl.ac.uk
Posted April 01, 2021.
SARS-CoV-2 binding to ACE2 triggers pericyte-mediated angiotensin-evoked cerebral capillary constriction
